Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial
Giovanni Landoni, Pratima Chowdary, Ferhat Meziani, Jacques Créteur et autres
Pulmonary intravascular thrombus formation has been widely observed in patients with respiratory failure, for example, in patients with SARS-CoV-2 infection (COVID-19). The aim of this study was to evaluate the efficacy/safety of alteplase thrombolysis in COVID-19 severe hypoxemic respiratory failure. In this …
it, gb, fr, be, de (code pays fourni par la source)
3 citations
Annals of Intensive Care